✦ LIBER ✦

Long-term remission in a patient with hepatosplenic gammadelta T cell lymphoma treated with bortezomib and high-dose CHOP-like chemotherapy followed by autologous peripheral stem cell transplantation

✍ Scribed by Zaher K. Otrock; Hassan A. Hatoum; Ziad M. Salem; Ayman Tawil; Rami A. Mahfouz; Ghazi S. Zaatari; Ali Bazarbachi

Publisher: Springer
Year: 2008
Tongue: English
Weight: 164 KB
Volume: 87
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-008-0523-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemotherapy with rituximab followed by

Chemotherapy with rituximab followed by high-dose therapy and autologous stem cell transplantation in patients with mantle cell lymphoma

✍ Catherine Thieblemont; Daciana Antal; Laurence Lacotte-Thierry; Vincent Delwail; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

## Abstract ## BACKGROUND The authors evaluated the efficacy of chemotherapy combined with rituximab followed by high‐dose therapy (HDT) plus autologous stem cell transplantation in patients with mantle cell lymphoma (MCL). ## METHODS This was a retrospective analysis of 34 patients who were tre

Long-Term Survival and Late-Onset Compli

Long-Term Survival and Late-Onset Complications of Cancer Patients Treated With High-Dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell Transplantation

✍ Kyuhei Kohda; Sumio Sakamaki; Takuya Matsunaga; Takashi Kuga; Akihito Fujimi; Yu 📂 Article 📅 2001 🏛 Carden Jennings Publishing 🌐 English ⚖ 90 KB

Long-term followup of health status in p

Long-term followup of health status in patients with severe rheumatoid arthritis after high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation

✍ Y. K. O. Teng; R. J. Verburg; J. K. Sont; W. B. Van Den Hout; F. C. Breedveld; J 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 2 views

The hyper-CVAD–rituximab chemotherapy pr

The hyper-CVAD–rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphoma

✍ D. S. Ritchie; J. F. Seymour; A. P. Grigg; A. W. Roberts; R. Hoyt; S. Thompson; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 113 KB

High-dose therapy and autologous periphe

High-dose therapy and autologous peripheral blood stem cells transplantation followed by a very low reduced intensity regimen with fludarabine + cyclophosphamide and allograft improve complete remission rate in de novo multiple myeloma patients

✍ Massimo Martino; Giuseppe Console; Giuseppe Irrera; Giulia Praticò; Caterina Ste 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB 👁 2 views

## Abstract The recent development of reduced intensity conditioning and allotransplantation (RICT) has opened a new way to assure engraftment of donor cells while reducing early transplant‐related mortality. We evaluated the combination of high‐dose therapy and autologous peripheral blood stem cel

A randomized trial of chemotherapy with

A randomized trial of chemotherapy with carmustine, etoposide, cytarabine, and melphalan (BEAM) plus peripheral stem cell transplantation (PBSCT) vs single-agent high-dose chemotherapy followed by BEAM plus PBSCT in patients with relapsed Hodgkin's disease (HD-R2)

✍ J.-P. Glossmann; A. Josting; B. Pfistner; U. Paulus; A. Engert; German Hodgkin's 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 90 KB